WO2002018494A1 - Resin composition - Google Patents

Resin composition Download PDF

Info

Publication number
WO2002018494A1
WO2002018494A1 PCT/JP2001/007343 JP0107343W WO0218494A1 WO 2002018494 A1 WO2002018494 A1 WO 2002018494A1 JP 0107343 W JP0107343 W JP 0107343W WO 0218494 A1 WO0218494 A1 WO 0218494A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
acid
resin composition
weight
polymerizable vinyl
Prior art date
Application number
PCT/JP2001/007343
Other languages
French (fr)
Japanese (ja)
Inventor
Toshio Shimamoto
Shigeru Sugiyama
Noboru Hoshi
Original Assignee
Daido Chemical Corporation
Nisshin Kasei Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daido Chemical Corporation, Nisshin Kasei Co., Ltd. filed Critical Daido Chemical Corporation
Priority to AU2001280194A priority Critical patent/AU2001280194A1/en
Publication of WO2002018494A1 publication Critical patent/WO2002018494A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances

Definitions

  • the present invention relates to (1) polyethylene glycol and a derivative thereof, wherein the resin film is dissolved or dispersed in water having a pH of 10 or less and is liquid at ordinary temperature, (2) medium-chain fatty acids and salts thereof, and (3) polyoxyethylene.
  • Resin composition which is not affected by at least one selected from the group consisting of sorbitan fatty acid ester, (4) polyoxyethylene castor oil, (5) diethylene glycol ether derivative, and (6) polyhydric alcohol and its derivative. It is about things. Background technology
  • resin films that dissolve or disperse under acidic conditions are used as gastric-soluble coating agents and gastric-soluble hard capsule bases, or resin films that do not dissolve under acidic conditions but dissolve or disperse near neutrality.
  • it has been used as an enteric coating agent and an enteric octacapsule base.
  • the present inventor has conducted intensive studies in view of the above-mentioned problems of the prior art, and as a result, has found that the following resin composition solves the problems.
  • the resin film dissolves or disperses in water below pH10 and is liquid at room temperature.
  • R 2 represents an alkylene group having 1 to 4 carbon atoms
  • R 3 and R 4 represent the same or different and represent 1 to 4 carbon atoms.
  • A represents an oxygen atom or NH.
  • Item 3 (a) From a solution obtained by dissolving chitosan having a degree of deacetylation of 60 mol% or more with an acid, or (mouth) chitosan having a degree of deacetylation of 60 mol% or more is acidified. After dissolving with at least one kind of polymerizable vinyl monomer, polymerize or copolymerize Item 2.
  • Item 4 In the presence of polyvinyl alcohol and / or a derivative thereof, at least one selected from the group consisting of an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer is polymerized or copolymerized.
  • (meth) acryl means acryl and methacryl.
  • (meth) acrylic acid means acrylic acid and methacrylic acid.
  • (meth) acrylate means acrylate and methacrylate.
  • dimethylaminoethyl (meth) acrylate means dimethylaminoethyl acrylate and dimethylaminoethyl methyl acrylate.
  • the resin composition of the present invention is characterized in that the resin film is dissolved or dispersed in water having a pH of 10 or less and is liquid at ordinary temperature; (1) polyethylene glycol and a derivative thereof; (2) a medium-chain fatty acid and a salt thereof; ) Polyoxyethylene sorbitan fatty acid ester, (4) polyoxyethylene castor oil, (5) diethylene glycol ether derivative, and (6) at least one selected from the group consisting of polyhydric alcohols and derivatives thereof.
  • the thickness of the resin film is appropriately selected according to its use, and for example, refers to a film having a thickness of about 0.01 to 5 mm, preferably about 0.05 to 1 mm.
  • not eroded means that the resin film does not dissolve in at least one of the compounds (1) to (6), does not show deterioration such as swelling, whitening, and cracking, and (1) to (6) Means that the compound does not pass through the resin film.
  • Examples of the above polyethylene glycol include polyethylene glycol having an average molecular weight of 2000 or less.
  • Examples of the polyethylene glycol derivative include polyethylene glycol alkyl ethers such as polyethylene glycol tridecyl ether and polyethylene glycol oleyl ether.
  • the above-mentioned medium-chain fatty acid is, for example, a saturated or unsaturated fatty acid having 6 to 12 carbon atoms. Examples include caproic acid, caprylic acid, capric acid, and lauric acid. Salts are sodium salt, lithium salt, potassium salt, ammonium salt, and alkylamine. And salt.
  • polyoxyethylene sorbitan fatty acid ester examples include those commonly used in pharmaceuticals and the like.
  • diethylene glycol ether derivative examples include diethylene glycol alkyl ethers such as diethylene glycol-diethyl ether, diethylene glycol dimethyl ether, diethylene glycol monoethyl ether, and ethylene glycol monomethyl ether.
  • polyhydric alcohol examples include ethylene glycol, propylene glycol, polypropylene glycol, glycerin and the like.
  • polyhydric alcohol derivative examples include propylene glycol alkyl ethers such as propylene glycol dimethyl ether and propylene glycol dibutyl ether, and glycerin ethers such as 1-methylglycerin ether and 1,3-dimethylglycerin ether.
  • glycerin fatty acid esters such as ters and glycerin oleate.
  • the polymerizable vinyl monomer represented by the general formula [1] is a derivative of acrylic acid or methacrylic acid.
  • it is dimethylaminoethyl methacrylate.
  • the amount of the polymerizable vinyl monomer represented by the general formula [1] to be used is determined based on the amount of the vinyl monomer, the organic acid having a polymerizable Bier group or a salt thereof and other polymerizable vinyl monomers It is from 10 to 50% by weight, preferably from 20 to 40% by weight, based on the total amount of the monomers. If the amount used is less than 10% by weight, the dissolution and dispersibility of the resin film under acid conditions may be poor. On the other hand, if the amount used exceeds 50% by weight, the film of the copolymer is affected by humidity, and it may not be possible to obtain sufficient strength under high humidity.
  • the copolymerization may be random copolymerization, block copolymerization, or graft copolymerization. Preferably, it is a random copolymerization.
  • the organic acid having a polymerizable vinyl group or a salt thereof is, for example, (meth) acrylic acid, fumaric acid, maleic acid, itaconic acid, or a sodium salt, potassium salt, ammonium salt, or alkylamine salt thereof. .
  • the amount of the organic acid having a polymerizable vinyl group such as (meth) acrylic acid and sodium (meth) acrylate or a salt thereof is the amount of the polymerizable biel monomer represented by the general formula [1], It is 10 to 50% by weight, preferably 25 to 40% by weight, based on the total amount of the organic acid having a polymerizable vinyl group or its salt and other vinyl monomers. If the amount is less than 10% by weight, the resin film may not have resistance to the dissolving agent. On the other hand, if the amount used exceeds 50% by weight, the copolymer film is affected by humidity and may not be able to obtain sufficient strength under low humidity.
  • the monomers include, for example, methyl (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-ethylhexyl (meth) acrylate Acrylate, acrylonitrile, acrylamide, dimethylacrylamide, styrene, vinyl acetate, hydroxyethyl (meth) acrylate, esters of polyethylene glycol or polypropylene glycol with (meth) acrylic acid, N-vinylpyrrolidone, acryloyl morpholine, etc. is there.
  • it is methyl methacrylate.
  • the polymerization initiator is used as needed, and those commonly used can be used.
  • 2,2'-azobis (2-amidinopropane) hydride azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate;
  • t-Butyl hydrid Redox initiators such as organic peroxides such as peroxides, hydrogen peroxide tartaric acid, and sodium hydrogen peroxide tartrate are used.
  • the amount of the other vinyl monomer used may be a polymerizable vinyl monomer represented by the general formula [1], an organic acid having a polymerizable vinyl group or a salt thereof, and other vinyl monomers. It is 0 to 80% by weight based on the total amount.
  • chitosan is obtained by treating chitin, which is contained in a large amount in shells of shellfish such as shrimp and shrimp, in a concentrated alkali to completely or partially deacetylate the acetyl group.
  • chitin which is contained in a large amount in shells of shellfish such as shrimp and shrimp
  • a concentrated alkali to completely or partially deacetylate the acetyl group.
  • it is limited to those having a degree of deacetylation of 60 mol% or more.
  • the degree of deacetylation is less than 60 mol%, the formability of the film may be deteriorated due to poor solubility in an acid solution.
  • the acid that dissolves chitosan is not particularly limited, as long as it has the ability to dissolve chitosan.
  • it is lactic acid.
  • acidic polymerizable vinyl monomers can also be used.
  • the resin composition of the present invention is obtained by dissolving chitosan with at least one kind of acidic polymerizable vinyl monomer and then performing a polymerization reaction.
  • the acidic polymerizable vinyl monomer include (meth) acrylic acid, fumaric acid, maleic acid, and itaconic acid.
  • (meth) acrylic acid is used.
  • the polymerization initiator is used as needed, and those commonly used can be used.
  • 2,2'-azobis (2-amidinopropane) hydride azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate; t-Butyl hydride Redox initiators such as organic peroxides such as peroxide, hydrogen peroxide monotartaric acid, and hydrogen peroxide-sodium tartrate are used.
  • Chitosan is dissolved, for example, under the following conditions.
  • the amount of the acid used is 0.8 to 2.0 mol%, preferably 0.9 to 1.2 mol%, based on 1 mol of chitosan.
  • chitosan has 1 mol of dalcosamine or N-acetyl-D-dalcosamine unit.
  • the degree of deacetylation of the chitosan used is at least 60%, preferably at least 80% For example, at 60, 23-33 g of lactate is used for 50 g of chitosan with a degree of deacetylation of 85%.
  • Polyvinyl alcohol (hereinafter abbreviated as PVA) and derivatives thereof used in the invention of Item 4 include, in addition to completely genated products, intermediate saponified products, partially saponified products, amine-modified PVA, ethylene-modified PVA, terminal Various modified PVAs such as thiol-modified PVA can be used.
  • the average degree of polymerization of PVA is not particularly limited, since it is sufficient to select an optimum concentration and viscosity according to the application.
  • the organic acid having a polymerizable vinyl group or a salt thereof is, for example, (meth) acrylic acid, fumaric acid, maleic acid, itaconic acid, or a sodium salt, potassium salt, ammonium salt, or alkylamine salt thereof.
  • (meth) acrylic acid is used.
  • the amount of the organic acid having a polymerizable biel group or a salt thereof is preferably 5 to 50, based on the total amount of the organic acid or a salt thereof having a polymerizable bier group and other vinyl monomers. % By weight, more preferably 10 to 40% by weight.
  • the amount of the organic acid having a polymerizable biel group or a salt thereof is less than 5% by weight, the ability of the obtained resin film to dissolve or disperse in water is slightly reduced as compared with the case where the amount is 5% by weight or more. There is a tendency, but there is no problem. Also, when the amount used exceeds 50% by weight, the obtained resin film tends to be slightly affected at low humidity under the influence of humidity as compared with the case where the amount is 50% by weight or less. No problem.
  • polymerizable vinyl monomers impart appropriate hardness and flexibility to the obtained resin composition.
  • Such monomers include, for example, methyl (meth) acrylate, ethyl (methyl) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-ethylhexyl (meth) acrylate.
  • it is methyl methacrylate.
  • the amount of the other polymerizable beer monomer used may be an organic acid having a polymerizable vinyl group or Is preferably 50 to 95% by weight based on the total amount of the salt and other Bier monomers. More preferably, it is 60 to 90% by weight.
  • the weight ratio of polyvinyl alcohol and Z or a derivative thereof to at least one selected from the group consisting of an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer is preferably , 20-95: 80-5, and more preferably 50-90: 50-10.
  • the weight ratio of PVA and Z or its derivative When the weight ratio of PVA and Z or its derivative is less than 20, the ability of the resulting resin film to dissolve or disperse in water tends to be slightly lower than when it is 20 or more, but this is not a problem. . When the weight ratio exceeds 95, the resulting resin film is affected by humidity and tends to have a slight decrease in high-humidity compared to a case where the weight ratio is 95 or less. Absent.
  • Item 4 The invention according to Item 4, including a copolymer obtained by copolymerizing an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer in the presence of polyvinyl alcohol and Z or a derivative thereof. Resin compositions are preferred.
  • the polymerization initiator is used as needed, and those commonly used can be used.
  • 2,2'-azobis (2-amidinopropane) hydride chloride azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate;
  • AIBN azoisobutyronitrile
  • persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate
  • t-Butyl hydride mouth Peroxides and other organic peroxides hydrogen peroxide monotartrate, hydrogen peroxide monotartrate
  • a redox initiator such as sodium is used.
  • the resin composition of the present invention can be used as a base material for hard capsules and soft capsules. It can also be used as a coating agent for coated tablets. Further, the resin composition of the present invention can be used for those conventionally used as microcapsules. For example, it is possible to supply the active ingredient by encapsulating the active ingredient of cosmetics in a capsule and crushing the capsule on a desired body surface. Further, the composition of the present invention can be used for preventing bad breath. That is, bad breath can be prevented by encapsulating a deodorant for preventing bad breath in a capsule produced with the composition of the present invention and dissolving the capsule in the stomach or the like.
  • the resin composition of the present invention can be used in foods.
  • it can be used as microcapsules to be put into a gum or the like.
  • the resin composition of the present invention can be used as microcapsules in mouthwash and toothpaste.
  • M-205 PVA having a thiol group at the end, polymerization degree 500, degree of saponification 88%, ) 5.9 g, M-215 (PVA with a terminal thiol group, polymerization degree 1500, degree of generification 88%, manufactured by Kuraray) 53.2 g and ion-exchanged water 236.9 g were charged 95 Completely dissolved at ° C. Next, 5.6 g of acrylic acid and 13. l g of methyl methacrylate were added, and the temperature was raised to 80 ° C after purging with nitrogen.
  • a reaction product was obtained in the same manner as in Example 4, except that acrylic acid was changed to methacrylic acid. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results.
  • Example 4 PVA M-205 was replaced with EG-05 (partially saponified PVA, polymerization degree 500, saponification degree 88%, manufactured by Nippon Gosei), and M-215 was replaced with EG-25 (partially saponified PVA, A reaction product was obtained in the same manner as in Example 4 except that the polymerization degree was changed to 1700, the saponification degree was 88%, and manufactured by Nippon Gosei. Using this, a film having a thickness of about 0.1 mm was produced on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results. Comparative Example 1
  • a reaction product was obtained in the same manner as in Example 1 except that the amount of acrylic acid was changed to 10 g and the amount of methyl methacrylate was changed to 70 g. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. The results are shown in Table 1. In evaluation tests 4 and 5, the films dissolved.
  • Hydroxypropylmethylcellulose (viscosity of a 2% aqueous solution at 20 ° C of 2.4-5.4 centistokes) was dissolved in deionized water. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results. In Evaluation Test 5, polyethylene glycol permeated the film and oozed out.
  • a film with a size of 2 O mm square was immersed in 10 ml of water and gently shaken to confirm that the film dissolved or dispersed.
  • a 20 mm square film was immersed in 10 ml of water of pH 1.2 prepared with hydrochloric acid and deionized water, and gently shaken to confirm whether the film dissolved or dispersed.
  • Evaluation test 3 Neutral area dissolution test of coating A 2 Omm square film was immersed in 10 ml of PH6.8 water prepared with potassium dihydrogen phosphate, sodium hydroxide, and deionized water, and gently shaken to confirm that the film dissolved or dispersed. .
  • a 20 mm square film was immersed in 10 ml of polyethylene glycol (molecular weight: 400) and left at 60 for one week to check whether the film deteriorated. ,
  • the film was supported horizontally, and an appropriate amount of PEG was dropped on the upper surface of the film, and allowed to stand for one week to check whether PEG permeated the film.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A resin composition is provided, which is not attacked by solvents used for the dissolution of slightly soluble drugs. This composition is characterized by not being attacked by at least one member selected from the group consisting of polyethylene glycol and derivatives thereof, medium-chain fatty acids and salts thereof, polyoxyethylene sorbitan fatty acid esters polyoxyethylene castor oils, diethylene glycol ether derivatives, and polyhydric alcohols and derivatives thereof, which are soluble or dispersible in water having a pH of 10 or below and liquid at ordinary temperatures.

Description

明 細 書  Specification
樹脂組成物 技 術 分 野 Resin composition technology field
本発明は、 樹脂皮膜が P H 1 0以下の水に溶解または分散し、 かつ常温で液体 の(1)ポリエチレングリコールおよびその誘導体、 (2)中鎖脂肪酸およびその塩、 (3)ポリォキシエチレンソルビ夕ン脂肪酸エステル、 (4)ポリォキシエチレンひま し油、 (5)ジエチレングリコールエーテル誘導体、 並びに(6)多価アルコールおよ びその誘導体からなる群から選択される少なくとも 1種に侵されない樹脂組成物 に関するものである。 背 景 技 術  The present invention relates to (1) polyethylene glycol and a derivative thereof, wherein the resin film is dissolved or dispersed in water having a pH of 10 or less and is liquid at ordinary temperature, (2) medium-chain fatty acids and salts thereof, and (3) polyoxyethylene. Resin composition which is not affected by at least one selected from the group consisting of sorbitan fatty acid ester, (4) polyoxyethylene castor oil, (5) diethylene glycol ether derivative, and (6) polyhydric alcohol and its derivative. It is about things. Background technology
高分子化合物の各種溶媒に対する溶解性、 耐性といった特徴は、 各産業分野に おいて様々に利用されている。  Features such as solubility and resistance of polymer compounds to various solvents are widely used in various industrial fields.
医薬では、 酸性条件で溶解もしくは分散する樹脂皮膜が、 胃溶性コ一ティング 剤や胃溶性ハードカプセル基剤に使用されたり、 逆に酸性条件では溶解せず、 中 性付近で溶解もしくは分散する樹脂皮膜が、 腸溶性コーティング剤や腸溶性八一 ドカプセル基剤に使用されたりしている。  In pharmaceuticals, resin films that dissolve or disperse under acidic conditions are used as gastric-soluble coating agents and gastric-soluble hard capsule bases, or resin films that do not dissolve under acidic conditions but dissolve or disperse near neutrality. However, it has been used as an enteric coating agent and an enteric octacapsule base.
しかし、 近年開発される医薬品の薬効成分には、 水への溶解性の悪いもの (難 溶性薬物) が多く、 消化管からの吸収性に問題が発生することが多い。 そのよう な難溶性薬物をいかに効率よく吸収させるかという様々な研究が行われてきた結 果、 常温で液体のポリエチレングリコールおよびその誘導体、 中鎖脂肪酸とその 塩、 ポリオキシエチレンソルビタン脂肪酸エステル、 ポリオキシエチレンひまし 油、 ジエチレングリコールエーテル誘導体、 多価アルコールおよびその誘導体等 の溶解剤に難溶性薬物を溶解した液体をカプセルに封入、 製剤化する手法が有効 であることが分かった。  However, many of the medicinal components of drugs developed in recent years have poor water solubility (poorly soluble drugs), and often cause problems in absorption from the gastrointestinal tract. Various studies have been conducted on how to efficiently absorb such poorly soluble drugs. As a result, polyethylene glycol and its derivatives, medium-chain fatty acids and their salts, polyoxyethylene sorbitan fatty acid esters, The method of encapsulating and formulating a liquid in which a poorly soluble drug was dissolved in a dissolving agent such as oxyethylene castor oil, diethylene glycol ether derivative, polyhydric alcohol and its derivative was found to be effective.
しかしながら、 これまでカプセルの基剤として一般に使われてきたゼラチンや セルロース誘導体に上記のような溶解剤を封入すると、 ゼラチンでは著しいカブ セルの強度の低下が、 セルロース誘導体では溶解剤がカプセル剤皮中を透過する 、 いわゆる 「汗かき」 現象を生じてしまうという問題があった。 発 明 の 開 示 However, if the above-mentioned dissolving agent is encapsulated in gelatin or cellulose derivatives that have been generally used as a base material of capsules, the gelatin has a significant decrease in capsule strength. Penetrate However, there was a problem that a so-called "sweat" phenomenon occurred. Disclosure of the invention
本発明者は、 上記従来技術の問題点に鑑み鋭意検討を重ねた結果、 以下の樹脂 組成物が問題点を解決することを見出した。  The present inventor has conducted intensive studies in view of the above-mentioned problems of the prior art, and as a result, has found that the following resin composition solves the problems.
項 1 . 樹脂皮膜が、 p H l 0以下の水に溶解または分散し、 かつ常温で液体のItem 1. The resin film dissolves or disperses in water below pH10 and is liquid at room temperature.
(1)ポリエチレングリコールおよびその誘導体、 (1) polyethylene glycol and its derivatives,
(2)中鎖脂肪酸およびその塩、  (2) medium-chain fatty acids and salts thereof,
(3)ポリォキシエチレンソルビタン脂肪酸エステル、  (3) polyoxyethylene sorbitan fatty acid ester,
(4)ポリォキシエチレンひまし油、 (4) Polyoxyethylene castor oil,
(5)ジエチレングリコールエーテル誘導体、 並びに  (5) a diethylene glycol ether derivative, and
(6)多価アルコールおよびその誘導体  (6) Polyhydric alcohol and its derivatives
からなる群から選択される少なくとも 1種に侵されないことを特徴とする樹脂組 成物。 A resin composition characterized by being unaffected by at least one member selected from the group consisting of:
項 2 . —般式 〔1〕 : Term 2. General formula [1]:
〔1〕
Figure imgf000004_0001
[1]
Figure imgf000004_0001
〔式中、 は水素原子またはメチル基を示し、 R 2は 1 ~ 4個の炭素原子を有す るアルキレン基を示し、 R 3および R 4は同一または異なって 1〜4個の炭素原子 を有するアルキル基を示し、 Aは酸素原子または NHを示す。 〕 [In the formula, represents a hydrogen atom or a methyl group, R 2 represents an alkylene group having 1 to 4 carbon atoms, and R 3 and R 4 represent the same or different and represent 1 to 4 carbon atoms. A represents an oxygen atom or NH. ]
で表される重合性ビニル単量体 1 0〜5 0重量%、 重合性ビニル基を有する有機 酸またはその塩 1 0〜5 0重量%および他の重合性ビニル単量体 0〜 8 0重量% を共重合させて得られる樹脂を含む項 1に記載の樹脂組成物。 10 to 50% by weight of a polymerizable vinyl monomer represented by the following formula: 10 to 50% by weight of an organic acid having a polymerizable vinyl group or a salt thereof and 0 to 80% by weight of another polymerizable vinyl monomer Item 1. The resin composition according to Item 1, which contains a resin obtained by copolymerizing%.
項 3 . (ィ) 脱ァセチル化度が 6 0モル%以上のキトサンを酸で溶解して得られ る溶解液から、 或いは (口) 脱ァセチル化度が 6 0モル%以上のキトサンを酸性 の重合性ビニル単量体の少なくとも 1種で溶解した後、 重合または共重合させて 得られる重合体または共重合体を含有する溶液から、 得られる樹脂を含む項 1に 記載の樹脂組成物。 Item 3. (a) From a solution obtained by dissolving chitosan having a degree of deacetylation of 60 mol% or more with an acid, or (mouth) chitosan having a degree of deacetylation of 60 mol% or more is acidified. After dissolving with at least one kind of polymerizable vinyl monomer, polymerize or copolymerize Item 2. The resin composition according to Item 1, which contains a resin obtained from a solution containing the obtained polymer or copolymer.
項 4 . ポリビニルアルコールおよび/またはその誘導体の存在下に、 重合性ビニ ル基を有する有機酸またはその塩およびその他の重合性ビニル単量体からなる群 から選択される少なくとも 1種を重合または共重合して得られる樹脂を含む請求 項 1に記載の樹脂組成物。 Item 4. In the presence of polyvinyl alcohol and / or a derivative thereof, at least one selected from the group consisting of an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer is polymerized or copolymerized. The resin composition according to claim 1, comprising a resin obtained by polymerization.
本明細書において、 (メタ) アクリルとは、 アクリル、 メタクリルを意味する 。 例えば、 (メタ) アクリル酸は、 アクリル酸、 メタクリル酸を意味する。 同様 に、 (メタ) ァクリレートとは、 ァクリレート、 メタクリレートを意味する。 例 えば、 ジメチルアミノエチル (メタ) ァクリレートは、 ジメチルアミノエチルァ クリレ一ト、 ジメチルァミノェチルメ夕クリレートを意味する。  In this specification, (meth) acryl means acryl and methacryl. For example, (meth) acrylic acid means acrylic acid and methacrylic acid. Similarly, (meth) acrylate means acrylate and methacrylate. For example, dimethylaminoethyl (meth) acrylate means dimethylaminoethyl acrylate and dimethylaminoethyl methyl acrylate.
本発明の樹脂組成物は、 樹脂皮膜が、 P H 1 0以下の水に溶解または分散し、 かつ常温で液体の(1)ポリエチレングリコールおよびその誘導体、 (2)中鎖脂肪酸 およびその塩、 (3)ポリオキシエチレンソルビタン脂肪酸エステル、 (4)ポリオキ シエチレンひまし油、 (5)ジエチレングリコールエーテル誘導体、 並びに(6)多価 アルコールおよびその誘導体からなる群から選択される少なくとも 1種に侵され ないものである。 樹脂皮膜の膜厚は、 その用途に応じ適宜選択されるが、 例えば 、 0 . 0 l〜5 mm程度、 好ましくは 0 . 0 5〜 1 mm程度の膜をいう。 また、 ここで、 侵されないとは、 樹脂皮膜が(1)〜(6)の少なくとも 1種の化合物に溶解 せず、 膨潤、 白化、 割れなどの劣化を示さず、 (1)〜(6)の化合物が樹脂皮膜を透 過しないことをいう。  The resin composition of the present invention is characterized in that the resin film is dissolved or dispersed in water having a pH of 10 or less and is liquid at ordinary temperature; (1) polyethylene glycol and a derivative thereof; (2) a medium-chain fatty acid and a salt thereof; ) Polyoxyethylene sorbitan fatty acid ester, (4) polyoxyethylene castor oil, (5) diethylene glycol ether derivative, and (6) at least one selected from the group consisting of polyhydric alcohols and derivatives thereof. The thickness of the resin film is appropriately selected according to its use, and for example, refers to a film having a thickness of about 0.01 to 5 mm, preferably about 0.05 to 1 mm. Here, the term “not eroded” means that the resin film does not dissolve in at least one of the compounds (1) to (6), does not show deterioration such as swelling, whitening, and cracking, and (1) to (6) Means that the compound does not pass through the resin film.
上記ポリエチレングリコールとしては、 例えば、 平均分子量 2 0 0 0以下のポ リエチレングリコールなどが挙げられる。 ポリエチレングリコール誘導体として は、 ポリエチレングリコールトリデシルエーテル、 ポリエチレングリコールォレ ィルエーテル等のポリエチレングリコールアルキルエーテル類などが挙げられる 上記中鎖脂肪酸は、 例えば、 炭素数 6〜1 2の飽和もしくは不飽和脂肪酸で、 カプロン酸、 力プリル酸、 力プリン酸、 ラウリン酸などが挙げられる。 また、 塩 とは、 ナトリウム塩、 リチウム塩、 カリウム塩、 アンモニゥム塩、 アルキルアミ ン塩などをいう。 Examples of the above polyethylene glycol include polyethylene glycol having an average molecular weight of 2000 or less. Examples of the polyethylene glycol derivative include polyethylene glycol alkyl ethers such as polyethylene glycol tridecyl ether and polyethylene glycol oleyl ether.The above-mentioned medium-chain fatty acid is, for example, a saturated or unsaturated fatty acid having 6 to 12 carbon atoms. Examples include caproic acid, caprylic acid, capric acid, and lauric acid. Salts are sodium salt, lithium salt, potassium salt, ammonium salt, and alkylamine. And salt.
上記ポリオキシエチレンソルビ夕ン脂肪酸エステルおよびポリオキシエチレン ひまし油としては、 医薬品などで通常使用されているものが挙げられる。  Examples of the polyoxyethylene sorbitan fatty acid ester and the polyoxyethylene castor oil include those commonly used in pharmaceuticals and the like.
上記ジエチレングリコールエーテル誘導体としては、 例えばジエチレングリコ —ルジェチルエーテル、 ジエチレングリコールジメチルエーテル、 ジエチレング リコールモノェチルエーテル、 ジェチレングリコールモノメチルェ一テル等のジ エチレングリコ一ルアルキルエーテルなどが挙げられる。  Examples of the diethylene glycol ether derivative include diethylene glycol alkyl ethers such as diethylene glycol-diethyl ether, diethylene glycol dimethyl ether, diethylene glycol monoethyl ether, and ethylene glycol monomethyl ether.
上記多価アルコールとしては、 例えばエチレングリコール、 プロピレングリコ ール、 ポリプロピレングリコール、 グリセリンなどが挙げられる。 上記多価アル コール誘導体としては、 例えば、 プロピレングリコ一ルジェチルエーテル、 プロ ピレングリコールジブチルエーテル等のプロピレングリコールアルキルエーテル 類や、 1一メチルグリセリンエーテル、 1, 3—ジメチルグリセリンエーテル等 のグリセリンェ一テル類、 グリセリンォレイン酸エステル等のグリセリン脂肪酸 エステルなどが挙げられる。  Examples of the polyhydric alcohol include ethylene glycol, propylene glycol, polypropylene glycol, glycerin and the like. Examples of the polyhydric alcohol derivative include propylene glycol alkyl ethers such as propylene glycol dimethyl ether and propylene glycol dibutyl ether, and glycerin ethers such as 1-methylglycerin ether and 1,3-dimethylglycerin ether. And glycerin fatty acid esters such as ters and glycerin oleate.
一般式 〔1〕 で表される重合性ビニル単量体は、 アクリル酸ないしメ夕クリル 酸の誘導体である。 例えば、 ジメチルアミノエチル (メタ) アタリレート、 ジメ チルァミノプロピル (メタ) ァクリレート、 ジメチルアミノエチル (メタ) ァク リルアミド、 ジメチルァミノプロピル (メタ) アクリルアミド、 ジェチルァミノ メチルメタクリレートなどである。 好ましくは、 ジメチルアミノエチルメタクリ レートである。  The polymerizable vinyl monomer represented by the general formula [1] is a derivative of acrylic acid or methacrylic acid. For example, dimethylaminoethyl (meth) acrylate, dimethylaminopropyl (meth) acrylate, dimethylaminoethyl (meth) acrylamide, dimethylaminopropyl (meth) acrylamide, getylaminomethyl methacrylate, and the like. Preferably, it is dimethylaminoethyl methacrylate.
項 2の発明において、 一般式 〔1〕 で表される重合性ビニル単量体の使用量は 、 当該ビニル単量体、 重合性ビエル基を有する有機酸またはその塩およびその他 の重合性ビニル単量体の合計量に対して 1 0〜5 0重量%、 好ましくは 2 0〜4 0重量%である。 使用量が 1 0重量%未満では、 樹脂皮膜の酸条件での溶解、 分 散性に劣ることがある。 一方、 使用量が 5 0重量%を越えると、 共重合体のフィ ルムは湿度の影響を受け、 高湿度下で十分な強度を得ることができなくなること がある。  In the invention of Item 2, the amount of the polymerizable vinyl monomer represented by the general formula [1] to be used is determined based on the amount of the vinyl monomer, the organic acid having a polymerizable Bier group or a salt thereof and other polymerizable vinyl monomers It is from 10 to 50% by weight, preferably from 20 to 40% by weight, based on the total amount of the monomers. If the amount used is less than 10% by weight, the dissolution and dispersibility of the resin film under acid conditions may be poor. On the other hand, if the amount used exceeds 50% by weight, the film of the copolymer is affected by humidity, and it may not be possible to obtain sufficient strength under high humidity.
共重合は、 ランダム共重合、 ブロック共重合、 グラフ卜共重合を問わない。 好 ましくは、 ランダム共重合である。 重合性ビニル基を有する有機酸またはその塩は、 例えば、 (メタ) アクリル酸 、 フマル酸、 マレイン酸、 ィタコン酸、 もしくはそれらのナトリウム塩、 力リウ ム塩、 アンモニゥム塩、 アルキルアミン塩などである。 The copolymerization may be random copolymerization, block copolymerization, or graft copolymerization. Preferably, it is a random copolymerization. The organic acid having a polymerizable vinyl group or a salt thereof is, for example, (meth) acrylic acid, fumaric acid, maleic acid, itaconic acid, or a sodium salt, potassium salt, ammonium salt, or alkylamine salt thereof. .
好ましくは、 (メタ) アクリル酸、 (メタ) アクリル酸ナトリウムなどである 重合性ビニル基を有する有機酸またはその塩の使用量は、 一般式 〔1〕 で表さ れる重合性ビエル単量体、 重合性ビニル基を有する有機酸またはその塩およびそ の他のビニル単量体の合計量に対して 1 0〜5 0重量%、 好ましくは 2 5〜 4 0 重量%である。 使用量が 1 0重量%未満では、 樹脂皮膜が溶解剤に対する耐性が なくなることがある。 一方、 使用量が 5 0重量%を越えると、 共重合体のフィル ムは湿度の影響を受け、 低湿度下で十分な強度を得ることができなくなることが ある。  Preferably, the amount of the organic acid having a polymerizable vinyl group such as (meth) acrylic acid and sodium (meth) acrylate or a salt thereof is the amount of the polymerizable biel monomer represented by the general formula [1], It is 10 to 50% by weight, preferably 25 to 40% by weight, based on the total amount of the organic acid having a polymerizable vinyl group or its salt and other vinyl monomers. If the amount is less than 10% by weight, the resin film may not have resistance to the dissolving agent. On the other hand, if the amount used exceeds 50% by weight, the copolymer film is affected by humidity and may not be able to obtain sufficient strength under low humidity.
その他のビニル単量体は、 得られる樹脂組成物に適度な硬度および柔軟性を与 えるために、 必要に応じて使用される。 当該単量体は、 例えば、 メチル (メタ) ァクリレート、 ェチル (メタ) ァクリレート、 ブチル (メタ) ァクリレート、 ィ ソブチル (メタ) ァクリレート、 シクロへキシル (メタ) ァクリレート、 2—ェ チルへキシル (メタ) ァクリレート、 アクリロニトリル、 アクリルアミド、 ジメ チルアクリルアミド、 スチレン、 酢酸ビニル、 ヒドロキシェチル (メタ) ァクリ レート、 ポリエチレングリコールもしくはポリプロピレングリコールと (メタ) アクリル酸とのエステル、 N—ビニルピロリドン、 ァクリロイルモルホリンなど である。 好ましくは、 メチルメタクリレートである。  Other vinyl monomers are used as needed in order to impart appropriate hardness and flexibility to the obtained resin composition. The monomers include, for example, methyl (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-ethylhexyl (meth) acrylate Acrylate, acrylonitrile, acrylamide, dimethylacrylamide, styrene, vinyl acetate, hydroxyethyl (meth) acrylate, esters of polyethylene glycol or polypropylene glycol with (meth) acrylic acid, N-vinylpyrrolidone, acryloyl morpholine, etc. is there. Preferably, it is methyl methacrylate.
重合開始剤は、 必要に応じて使用され、 通常使用されているものを用いること ができる。 例えば、 2, 2 '—ァゾビス (2—アミジノプロパン) ハイド口クロラ イド、 A I B N (ァゾイソプチロニトリル) などのァゾ化合物、 過硫酸カリウム 、 過硫酸ナトリウム、 過硫酸アンモニゥムなどの過硫酸塩、 t一ブチルハイド口 パーオキサイドなどの有機過酸化物、 過酸化水素一酒石酸、 過酸化水素一酒石酸 ナトリウムなどのレドックス開始剤等が使用される。  The polymerization initiator is used as needed, and those commonly used can be used. For example, 2,2'-azobis (2-amidinopropane) hydride, azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate; t-Butyl hydrid Redox initiators such as organic peroxides such as peroxides, hydrogen peroxide tartaric acid, and sodium hydrogen peroxide tartrate are used.
その他のビニル単量体の使用量は、 一般式 〔1〕 で表される重合性ビニル単量 体、 重合性ビニル基を有する有機酸またはその塩およびその他のビニル単量体の 合計量に対して 0〜8 0重量%である。 The amount of the other vinyl monomer used may be a polymerizable vinyl monomer represented by the general formula [1], an organic acid having a polymerizable vinyl group or a salt thereof, and other vinyl monomers. It is 0 to 80% by weight based on the total amount.
項 3の発明において、 キトサンは力二、 ェビ等の甲殻類の外殻に多量に含有さ れているキチンを濃アルカリ中で処理し、 ァセチル基を完全にあるいは部分的に 脱ァセチル化したものであるが、 本発明では、 脱ァセチル化度が 6 0モル%以上 であるものに限定して使用される。 脱ァセチル化度が 6 0モル%未満の場合には 、 酸溶液への溶解性が劣る めに皮膜の成形性が悪くなることがある。  In the invention of Item 3, chitosan is obtained by treating chitin, which is contained in a large amount in shells of shellfish such as shrimp and shrimp, in a concentrated alkali to completely or partially deacetylate the acetyl group. However, in the present invention, it is limited to those having a degree of deacetylation of 60 mol% or more. When the degree of deacetylation is less than 60 mol%, the formability of the film may be deteriorated due to poor solubility in an acid solution.
キトサンを溶解する酸は、 特に限定されず、 キトサンを溶解する能力を有して いればよい。 例えば、 蟻酸、 酢酸、 n—酪酸、 乳酸、 ダルコン酸、 安息香酸、 塩 酸、 シユウ酸、 アジピン酸、 リンゴ酸、 酒石酸、 クェン酸、 (メタ) アクリル酸 、 フマル酸、 マレイン酸、 ィタコン酸、 グリコール酸などである。  The acid that dissolves chitosan is not particularly limited, as long as it has the ability to dissolve chitosan. For example, formic acid, acetic acid, n-butyric acid, lactic acid, dalconic acid, benzoic acid, hydrochloric acid, oxalic acid, adipic acid, malic acid, tartaric acid, citric acid, (meth) acrylic acid, fumaric acid, maleic acid, itaconic acid, Glycolic acid and the like.
好ましくは、 乳酸である。 Preferably, it is lactic acid.
さらに、 酸性の重合性ビニル単量体も使用することができる。 酸性の重合性ビ 二ル単量体を使用する場合には、 酸性の重合性ビニル単量体の少なくとも 1種で キトサンを溶解後、 重合反応を行うことにより、 本発明の樹脂組成物を得ること ができる。 酸性の重合性ビニル単量体としては、 例えば、 (メタ) アクリル酸、 フマル酸、 マレイン酸、 ィタコン酸などが挙げられる。  Further, acidic polymerizable vinyl monomers can also be used. When an acidic polymerizable vinyl monomer is used, the resin composition of the present invention is obtained by dissolving chitosan with at least one kind of acidic polymerizable vinyl monomer and then performing a polymerization reaction. be able to. Examples of the acidic polymerizable vinyl monomer include (meth) acrylic acid, fumaric acid, maleic acid, and itaconic acid.
好ましくは、 (メタ) アクリル酸である。  Preferably, (meth) acrylic acid is used.
重合開始剤は、 必要に応じて使用され、 通常使用されているものを用いること ができる。 例えば、 2, 2 '—ァゾビス (2—アミジノプロパン) ハイド口クロラ イド、 A I B N (ァゾイソプチロニトリル) などのァゾ化合物、 過硫酸カリウム 、 過硫酸ナトリウム、 過硫酸アンモニゥムなどの過硫酸塩、 t 一ブチルハイド口 パーォキサイドなどの有機過酸化物、 過酸化水素一酒石酸、 過酸化水素—酒石酸 ナトリウムなどのレドックス開始剤等が使用される。  The polymerization initiator is used as needed, and those commonly used can be used. For example, 2,2'-azobis (2-amidinopropane) hydride, azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate; t-Butyl hydride Redox initiators such as organic peroxides such as peroxide, hydrogen peroxide monotartaric acid, and hydrogen peroxide-sodium tartrate are used.
キトサンは例えば以下の条件で溶解される。  Chitosan is dissolved, for example, under the following conditions.
使用する酸の量は、 キトサンの 1モル量に対して、 0 . 8〜2 . 0モル%、 好ま しくは 0 . 9〜1 . 2モル%である。 ただし、 キトサンはダルコサミンまたは N —ァセチル— D—ダルコサミン単位を 1モルとする。 The amount of the acid used is 0.8 to 2.0 mol%, preferably 0.9 to 1.2 mol%, based on 1 mol of chitosan. However, chitosan has 1 mol of dalcosamine or N-acetyl-D-dalcosamine unit.
使用するキトサンの脱ァセチル化度は 6 0 %以上、 好ましくは 8 0 %以上である 例えば、 6 0でにおいて、 脱ァセチル化度 8 5 %のキトサン 5 0 gに対し、 乳 酸 2 3〜3 3 gが使用される。 The degree of deacetylation of the chitosan used is at least 60%, preferably at least 80% For example, at 60, 23-33 g of lactate is used for 50 g of chitosan with a degree of deacetylation of 85%.
項 4の発明において使用されるポリビニルアルコール (以後 P VAと略する) およびその誘導体は、 完全ゲン化物、 中間ケン化物、 部分ケン化物の他に、 アミ ン変性 P VA、 エチレン変性 P VA、 末端チオール変性 P VAなどの各種変性 P V Aを使用できる。 また、 P V Aの平均重合度は用途に応じた、 濃度、 粘度で最 適なものを選択すればよいのであって、 限定されるものでない。  Polyvinyl alcohol (hereinafter abbreviated as PVA) and derivatives thereof used in the invention of Item 4 include, in addition to completely genated products, intermediate saponified products, partially saponified products, amine-modified PVA, ethylene-modified PVA, terminal Various modified PVAs such as thiol-modified PVA can be used. In addition, the average degree of polymerization of PVA is not particularly limited, since it is sufficient to select an optimum concentration and viscosity according to the application.
重合性ビニル基を有する有機酸またはその塩は、 例えば、 (メタ) アクリル酸 、 フマル酸、 マレイン酸、 ィタコン酸、 もしくはそれらのナトリウム塩、 力リウ ム塩、 アンモニゥム塩、 アルキルアミン塩などである。 好ましくは、 (メタ) ァ クリル酸などである。  The organic acid having a polymerizable vinyl group or a salt thereof is, for example, (meth) acrylic acid, fumaric acid, maleic acid, itaconic acid, or a sodium salt, potassium salt, ammonium salt, or alkylamine salt thereof. . Preferably, (meth) acrylic acid is used.
重合性ビエル基を有する有機酸またはその塩の使用量は、 重合性ビエル基を有 する有機酸またはその塩およびその他のビニル単量体の合計量に対して、 好まし くは 5〜5 0重量%、 さらに好ましくは 1 0〜4 0重量%である。 重合性ビエル 基を有する有機酸またはその塩の使用量が 5重量%未満の場合、 5重量%以上の 場合と比較して、 得られる樹脂のフィルムが水に溶解または分散する能力が若干 低下する傾向があるが問題はない。 また、 使用量が 5 0重量%を超える場合、 5 0重量%以下の場合と比較して、 得られる樹脂のフィルムが湿度の影響を受け、 低湿度下で若干強度が低下する傾向があるが問題はない。  The amount of the organic acid having a polymerizable biel group or a salt thereof is preferably 5 to 50, based on the total amount of the organic acid or a salt thereof having a polymerizable bier group and other vinyl monomers. % By weight, more preferably 10 to 40% by weight. When the amount of the organic acid having a polymerizable biel group or a salt thereof is less than 5% by weight, the ability of the obtained resin film to dissolve or disperse in water is slightly reduced as compared with the case where the amount is 5% by weight or more. There is a tendency, but there is no problem. Also, when the amount used exceeds 50% by weight, the obtained resin film tends to be slightly affected at low humidity under the influence of humidity as compared with the case where the amount is 50% by weight or less. No problem.
その他の重合性ビニル単量体は、 得られる樹脂組成物に適度な硬度および柔軟 性を与える。 当該単量体は、 例えば、 メチル (メタ) ァクリレート、 ェチル (メ 夕) ァクリレート、 ブチル (メタ) ァクリレート、 イソブチル (メタ) ァクリレ —ト、 シクロへキシル (メタ) ァクリレート、 2—ェチルへキシル (メタ) ァク リレート、 アクリロニトリル、 アクリルアミド、 ジメチルアクリルアミド、 スチ レン、 酢酸ビニル、 ヒドロキシェチル (メタ) ァクリレ一ト、 ポリエチレンダリ コールもしくはポリプロピレングリコールと (メタ) アクリル酸とのエステル、 N -ビニルピロリドン、 ァクリロイルモルホリンなどである。  Other polymerizable vinyl monomers impart appropriate hardness and flexibility to the obtained resin composition. Such monomers include, for example, methyl (meth) acrylate, ethyl (methyl) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-ethylhexyl (meth) acrylate. ) Acrylate, acrylonitrile, acrylamide, dimethylacrylamide, styrene, vinyl acetate, hydroxyethyl (meth) acrylate, ester of poly (ethylene glycol) or polypropylene glycol with (meth) acrylic acid, N-vinylpyrrolidone, a And cryloylmorpholine.
好ましくは、 メチルメタクリレートである。 Preferably, it is methyl methacrylate.
その他の重合性ビエル単量体の使用量は、 重合性ビニル基を有する有機酸また はその塩およびその他のビエル単量体の合計量に対して、 好ましくは 5 0〜 9 5 重量%である。 さらに好ましくは 6 0〜9 0重量%である。 The amount of the other polymerizable beer monomer used may be an organic acid having a polymerizable vinyl group or Is preferably 50 to 95% by weight based on the total amount of the salt and other Bier monomers. More preferably, it is 60 to 90% by weight.
また、 ポリビニルアルコールおよび Zまたはその誘導体と、 重合性ビニル基を 有する有機酸またはその塩およびその他の重合性ビニル単量体からなる群から選 択される少なくとも 1種との重量比は、 好ましくは、 2 0〜9 5 : 8 0〜5であ り、 さらに好ましくは、 5 0〜9 0 : 5 0〜1 0である。  The weight ratio of polyvinyl alcohol and Z or a derivative thereof to at least one selected from the group consisting of an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer is preferably , 20-95: 80-5, and more preferably 50-90: 50-10.
P V Aおよび Zまたはその誘導体の重量比が 2 0未満の場合、 2 0以上の場合 と比較して、 得られる樹脂のフィルムが水に溶解または分散する能力が若干低下 する傾向があるが問題はない。 また、 重量比が 9 5を超える場合、 9 5以下の場 合と比較して、 得られる樹脂のフィルムが湿度の影響を受け、 高湿度下で若干強 度が低下する傾向があるが問題はない。  When the weight ratio of PVA and Z or its derivative is less than 20, the ability of the resulting resin film to dissolve or disperse in water tends to be slightly lower than when it is 20 or more, but this is not a problem. . When the weight ratio exceeds 95, the resulting resin film is affected by humidity and tends to have a slight decrease in high-humidity compared to a case where the weight ratio is 95 or less. Absent.
項 4の発明において、 ポリビニルアルコールおよび Zまたはその誘導体存在下 に、 重合性ビニル基を有する有機酸またはその塩とその他の重合性ビニル単量体 とを共重合して得られる共重合体を含む樹脂組成物が好ましい。  Item 4. The invention according to Item 4, including a copolymer obtained by copolymerizing an organic acid having a polymerizable vinyl group or a salt thereof and another polymerizable vinyl monomer in the presence of polyvinyl alcohol and Z or a derivative thereof. Resin compositions are preferred.
また、 項 4の発明において、 ポリビニルアルコールおよび Zまたはその誘導体 存在下に、 重合性ビニル基を有する有機酸またはその塩 5〜 5 0重量%とその他 の重合性ビニル単量体 5 0 - 9 5重量%とを共重合して得られる共重合体を含む 樹脂組成物 (ただし、 ポリビニルアルコールおよび またはその誘導体と重合性 ビニル単量体との重量比は 2 0〜9 5 : 8 0〜5である) がさらに好ましい。 重合または共重合の方法は、 公知の方法を使用できるが、 例えば、 水に P VA および Zまたはその誘導体を添加し、 加温して溶解し、 次いで重合性ビニル基を 有する有機酸またはその塩およびその他の重合性ビエル単量体からなる群から選 択される少なくとも 1種と重合開始剤とを添加し、 重合または共重合させて樹脂 を得ることができる。  In addition, in the invention of Item 4, in the presence of polyvinyl alcohol and Z or a derivative thereof, 5 to 50% by weight of an organic acid having a polymerizable vinyl group or a salt thereof and 50 to 95% of another polymerizable vinyl monomer % By weight of a resin composition containing a copolymer obtained by copolymerization with polyvinyl alcohol and / or a derivative thereof and a polymerizable vinyl monomer in a weight ratio of 20 to 95:80 to 5 Is more preferred. As the polymerization or copolymerization method, known methods can be used.For example, PVA and Z or a derivative thereof are added to water, heated and dissolved, and then an organic acid having a polymerizable vinyl group or a salt thereof. And at least one selected from the group consisting of polymerizable biel monomers and a polymerization initiator, and polymerizing or copolymerizing to obtain a resin.
重合開始剤は、 必要に応じて使用され、 通常使用されているものを用いること ができる。 例えば、 2 , 2 '—ァゾビス (2—アミジノプロパン) ハイド口クロラ イド、 A I B N (ァゾイソプチロニトリル) などのァゾ化合物、 過硫酸カリウム 、 過硫酸ナトリウム、 過硫酸アンモニゥムなどの過硫酸塩、 t一ブチルハイド口 パーオキサイドなどの有機過酸化物、 過酸化水素一酒石酸、 過酸化水素一酒石酸 ナトリウムなどのレドックス開始剤等が使用される。 The polymerization initiator is used as needed, and those commonly used can be used. For example, 2,2'-azobis (2-amidinopropane) hydride chloride, azo compounds such as AIBN (azoisobutyronitrile), persulfates such as potassium persulfate, sodium persulfate, and ammonium persulfate; t-Butyl hydride mouth Peroxides and other organic peroxides, hydrogen peroxide monotartrate, hydrogen peroxide monotartrate A redox initiator such as sodium is used.
本発明の樹脂組成物は、 硬カプセル剤および軟カプセル剤の剤皮の基剤として 使用できる。 またコーティング錠のコーティング剤として使用できる。 また、 本 発明の樹脂組成物は従来マイクロカプセルとして使用されていたものにも使用で きる。 例えば、 化粧品の有効成分をカプセルに封入し、 所望の体表面でカプセル をつぶすことにより、 有効成分を供給することが可能である。 さらに、 本発明の 組成物は口臭防止にも使用できる。 即ち、 本発明の組成物で製造したカプセルに 口臭防止用消臭剤を封入し、 胃等でカプセルを溶解させることにより口臭を防止 することができる。  The resin composition of the present invention can be used as a base material for hard capsules and soft capsules. It can also be used as a coating agent for coated tablets. Further, the resin composition of the present invention can be used for those conventionally used as microcapsules. For example, it is possible to supply the active ingredient by encapsulating the active ingredient of cosmetics in a capsule and crushing the capsule on a desired body surface. Further, the composition of the present invention can be used for preventing bad breath. That is, bad breath can be prevented by encapsulating a deodorant for preventing bad breath in a capsule produced with the composition of the present invention and dissolving the capsule in the stomach or the like.
また、 本発明の樹脂組成物は食品においても使用可能である。 例えば、 ガム等 に入れられるマイクロカプセルとして使用できる。 さらには、 マウスゥォッシュ や練り歯磨きに本発明の樹脂組成物をマイクロカプセルとして使用できる。 発明を実施するための最良の形態  Further, the resin composition of the present invention can be used in foods. For example, it can be used as microcapsules to be put into a gum or the like. Further, the resin composition of the present invention can be used as microcapsules in mouthwash and toothpaste. BEST MODE FOR CARRYING OUT THE INVENTION
以下、 実施例および比較例を示し、 本発明を具体的に説明するが、 本発明は下 記の実施例に制限されるものでない。 また、 %は全て重量%を示す。  EXAMPLES Hereinafter, the present invention will be described specifically with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples. In addition, all% indicate weight%.
実施例 1  Example 1
冷却還流管、 滴下ロート、 温度計、 窒素導入管および攪拌装置を取り付けたセ パラブルフラスコにアクリル酸 2 5 g、 ジメチルアミノエチルメタクリレート 2 0 g、 メチルメタクリレート 5 5 g、 ジメチルホルムアミド 4 0 0 g、 ァゾビス イソプチロニトリル 0 . 2 gからなる混合物を仕込み、 窒素を吹き込みながら 8 0 で 4時間重合を行った。 反応後、 室温まで冷却した溶液をアセトン中で分離 し、 分離物を水酸化ナトリウムで中和しながらイオン交換水に溶解し反応物を得 た。 これを用いて、 厚さ約 0 . 1 mmのフィルムをガラス板上に作製し、 以下の 評価試験 1〜5を行った。 結果を表 1に示す。  25 g of acrylic acid, 20 g of dimethylaminoethyl methacrylate, 55 g of methyl methacrylate, 400 g of dimethylformamide in a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube and a stirrer Then, a mixture consisting of 0.2 g of azobisisobutyronitrile was charged, and polymerization was carried out at 80 for 4 hours while blowing nitrogen. After the reaction, the solution cooled to room temperature was separated in acetone, and the separated product was dissolved in ion-exchanged water while neutralizing with sodium hydroxide to obtain a reaction product. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and the following evaluation tests 1 to 5 were performed. Table 1 shows the results.
実施例 2  Example 2
冷却還流管、 滴下ロート、 温度計、 窒素導入管および攪拌装置を取り付けたセ パラブルフラスコにフレーク状のキトサン (脱ァセチル化度 8 5 %) 5 0 g、 ィ オン交換水 4 2 7 g、 乳酸 2 3 gを仕込み攪拌下に 7 O 、 1時間で溶解し反応 物を得た。 これを用いて、 厚さ約 0. 1mmのフィルムをガラス板上に作製し、 評価試験 1〜5を行った。 結果を表 1に示す。 50 g of flaky chitosan (degree of deacetylation: 85%) in a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube, and a stirrer, and ion exchange water, 42 g, 23 g of lactic acid was charged and dissolved under stirring at 7 O for 1 hour to react. I got something. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results.
実施例 3  Example 3
冷却還流管、 滴下ロート、 温度計、 窒素導入管および攪拌装置を取り付けたセ パラブルフラスコにフレーク状のキトサン (脱ァセチル化度 85%) 50 g、 ィ オン交換水 431. 5 g、 アクリル酸 18. 5 gを仕込み攪拌下に 70 、 1時 間で溶解し、 窒素置換後、 過硫酸ナトリウム 0. 37 gを添加し 4時間で反応を 終了し反応物を得た。 これを用いて、 厚さ約 0. 1mmのフィルムをガラス板上 に作製し、 評価試験 1〜 5を行った。 結果を表 1に示す。  50 g of flaky chitosan (85% deacetylation degree), 431.5 g of ion-exchanged water, acrylic acid in a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube and a stirrer 18.5 g was charged and dissolved with stirring for 70 hours and 1 hour. After purging with nitrogen, 0.37 g of sodium persulfate was added and the reaction was completed in 4 hours to obtain a reaction product. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results.
実施例 4  Example 4
冷却還流管、 滴下ロート、 温度計、 窒素導入管および攪拌装置を取り付けたセ パラブルフラスコに、 M— 205 (末端にチオール基を有する PVA、 重合度 5 00、 ケン化度 88%、 クラレ製) 5. 9 g、 M— 215 (末端にチォ一ル基を 有する PVA、 重合度 1500、 ゲン化度 88%、 クラレ製) 53. 2 gとィォ ン交換水 236. 9 gを仕込み 95 °Cで完全溶解させた。 次いでアクリル酸 5. 6 g、 メチルメタクリレート 13. l gを添加し、 窒素置換後 80°Cまで昇温し た。 ターシャリーブチル八イドロパ一オキサイド 3 gを添加し、 4時間で反応を 終了し反応物を得た。 これを用いて、 厚さ約 0. 1mmのフィルムをガラス板上 に作製し、 評価試験 1〜 5を行った。 結果を表 1に示す。  In a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube and a stirrer, add M-205 (PVA having a thiol group at the end, polymerization degree 500, degree of saponification 88%, ) 5.9 g, M-215 (PVA with a terminal thiol group, polymerization degree 1500, degree of generification 88%, manufactured by Kuraray) 53.2 g and ion-exchanged water 236.9 g were charged 95 Completely dissolved at ° C. Next, 5.6 g of acrylic acid and 13. l g of methyl methacrylate were added, and the temperature was raised to 80 ° C after purging with nitrogen. 3 g of tert-butyl hydroxide was added, and the reaction was completed in 4 hours to obtain a reaction product. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results.
実施例 5  Example 5
実施例 4においてァクリル酸をメタクリル酸に変更した以外は実施例 4と同様 にし反応物を得た。 これを用いて、 厚さ約 0. 1mmのフィルムをガラス板上に 作製し、 評価試験 1〜5を行った。 結果を表 1に示す。  A reaction product was obtained in the same manner as in Example 4, except that acrylic acid was changed to methacrylic acid. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results.
実施例 6  Example 6
実施例 4において P VAの M— 205を EG— 05 (部分ケン化 PVA、 重合 度 500、 ケン化度 88%、 日本合成製) に、 M— 215を EG— 25 (部分ケ ン化 PVA、 重合度 1700、 ケン化度 88%、 日本合成製) に変更した以外は 実施例 4と同様にし反応物を得た。 これを用いて、 厚さ約 0. 1mmのフィルム をガラス板上に作製し、 評価試験 1〜 5を行なった。 結果を表 1に示す。 比較例 1 In Example 4, PVA M-205 was replaced with EG-05 (partially saponified PVA, polymerization degree 500, saponification degree 88%, manufactured by Nippon Gosei), and M-215 was replaced with EG-25 (partially saponified PVA, A reaction product was obtained in the same manner as in Example 4 except that the polymerization degree was changed to 1700, the saponification degree was 88%, and manufactured by Nippon Gosei. Using this, a film having a thickness of about 0.1 mm was produced on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results. Comparative Example 1
実施例 1のアクリル酸量を 1 0 gに、 メチルメタクリレ一ト量を 7 0 gに変更 した以外は実施例 1と同様にし反応物を得た。 これを用いて、 厚さ約 0 . l mm のフィルムをガラス板上に作製し、 評価試験 1〜5を行った。 結果を表 1に示す 。 評価試験 4および 5においてフィルムが溶解した。  A reaction product was obtained in the same manner as in Example 1 except that the amount of acrylic acid was changed to 10 g and the amount of methyl methacrylate was changed to 70 g. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. The results are shown in Table 1. In evaluation tests 4 and 5, the films dissolved.
比較例 2  Comparative Example 2
キトサンの脱ァセチル化度を 5 5 %に変更した以外は実施例 2と同様に調整し たが、 完全にはキトサンを溶解することができずフィルムを作製することはでき なかった。  The adjustment was carried out in the same manner as in Example 2 except that the degree of deacetylation of chitosan was changed to 55%, but the film could not be produced because chitosan could not be completely dissolved.
比較例 3  Comparative Example 3
市販のゼラチン (牛、 豚または魚由来のゼラチンでブルーム強度が 2 0 0〜3 0 0グラム) を脱イオン水で溶解した。 これを用いて、 厚さ約 0 . l mmのフィ ルムをガラス板上に作製し、 評価試験 1〜5を行った。 結果を表 1に示す。 評価 試験 4においてフィルムが脆化し、 評価試験 5においてポリエチレングリコール がフィルムを透過し、 にじみ出た。  Commercially available gelatin (gelatin from cattle, pigs or fish with a bloom strength of 200-300 grams) was dissolved in deionized water. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results. In Evaluation Test 4, the film was embrittled, and in Evaluation Test 5, polyethylene glycol permeated the film and bleed out.
比較例 4  Comparative Example 4
ヒドロギシプロピルメチルセルロース (2 %水溶液の 2 0 °Cにおける粘度が 2 . 4〜5 . 4センチストークス) を脱イオン水で溶解した。 これを用いて、 厚さ 約 0 . l mmのフィルムをガラス板上に作製し、 評価試験 1〜 5を行った。 結果 を表 1に示す。 評価試験 5においてポリエチレングリコールがフィルムを透過し 、 にじみ出た。  Hydroxypropylmethylcellulose (viscosity of a 2% aqueous solution at 20 ° C of 2.4-5.4 centistokes) was dissolved in deionized water. Using this, a film having a thickness of about 0.1 mm was formed on a glass plate, and evaluation tests 1 to 5 were performed. Table 1 shows the results. In Evaluation Test 5, polyethylene glycol permeated the film and oozed out.
評価試験 1 :皮膜の水溶解試験  Evaluation test 1: Water dissolution test of film
2 O mm角の大きさの皮膜を 1 0 m lの水に浸し、 静かに振り混ぜ皮膜が溶解 もしくは分散するか確認した。  A film with a size of 2 O mm square was immersed in 10 ml of water and gently shaken to confirm that the film dissolved or dispersed.
評価試験 2 :皮膜の酸溶解試験  Evaluation test 2: Acid dissolution test of film
2 0 mm角の大きさの皮膜を塩酸と脱イオン水で調製した p H l . 2の水 1 0 m lに浸し、 静かに振り混ぜ皮膜が溶解もしくは分散するか確認した。  A 20 mm square film was immersed in 10 ml of water of pH 1.2 prepared with hydrochloric acid and deionized water, and gently shaken to confirm whether the film dissolved or dispersed.
評価試験 3 :皮膜の中性領域溶解試験 2 Omm角の大きさの皮膜をリン酸二水素カリウムと水酸化ナトリウム、 脱ィ オン水で調製した PH6. 8の水 10mlに浸し、 静かに振り混ぜ皮膜が溶解も しくは分散するか確認した。 Evaluation test 3: Neutral area dissolution test of coating A 2 Omm square film was immersed in 10 ml of PH6.8 water prepared with potassium dihydrogen phosphate, sodium hydroxide, and deionized water, and gently shaken to confirm that the film dissolved or dispersed. .
評価試験 4:皮膜の耐ポリエチレングリコール (PEG) 試験  Evaluation test 4: Polyethylene glycol (PEG) resistance test of the film
20mm角の大きさの皮膜をポリエチレングリコール (分子量 400) 10m 1中に浸し 60 で一週間放置し、 フィルムが劣化するか確認した。,  A 20 mm square film was immersed in 10 ml of polyethylene glycol (molecular weight: 400) and left at 60 for one week to check whether the film deteriorated. ,
評価試験 5 :皮膜透過性試験  Evaluation test 5: Film permeability test
フィルムを水平に支持し、 フィルム上面に適量の PEGを滴下し、 一週間放置 して PEGがフィルムを透過するか確認した。  The film was supported horizontally, and an appropriate amount of PEG was dropped on the upper surface of the film, and allowed to stand for one week to check whether PEG permeated the film.
Figure imgf000014_0001
Figure imgf000014_0001
水、 酸性、 中性溶解試験:〇 完全に溶解または崩壊 Water, acidic, neutral dissolution test: 溶解 completely dissolved or disintegrated
X 溶解または崩壊せず  X does not dissolve or disintegrate
耐 PEG試験:〇 変化なし PEG resistance test: No change
X 溶解、 脆化など劣化あり  X Degradation such as melting and embrittlement
皮膜透過性試験:〇 フィルム透過せず Membrane permeability test: No film penetration
X フィルム透過あり (比較例 1では皮膜が溶解した) ) 産業上の利用の可能性 X Film penetrated (Comparative Example 1 dissolves the film) Industrial applicability
本発明により、 p H 1 0以下の水に溶解または分散し、 かつ常温で液体の溶解 剤に侵されない樹脂組成物を提供することができる。  According to the present invention, it is possible to provide a resin composition which is dissolved or dispersed in water having a pH of 10 or less and which is not affected by a liquid solvent at room temperature.

Claims

請 求 の 範 囲 The scope of the claims
1 . 樹脂皮膜が、 p H l 0以下の水に溶解または分散し、 力 常温で液体の1. The resin film dissolves or disperses in water of pH
(1)ポリエチレングリコールおよびその誘導体、 (1) polyethylene glycol and its derivatives,
(2)中鎖脂肪酸およびその塩、  (2) medium-chain fatty acids and salts thereof,
(3)ポリオキシエチレンソルビ夕ン脂肪酸エステル、 (3) polyoxyethylene sorbitan fatty acid ester,
(4)ポリオキシエチレンひまし油、  (4) polyoxyethylene castor oil,
(5)ジエチレングリコールエーテル誘導体、 並びに  (5) a diethylene glycol ether derivative, and
(6)多価アルコールぉよびその誘導体  (6) Polyhydric alcohol and its derivatives
からなる群から選択される少なくとも 1種に侵されないことを特徴とする樹脂組 成物。 A resin composition characterized by being unaffected by at least one member selected from the group consisting of:
2 . 一般式 〔1〕 :  2. General formula [1]:
〔1〕
Figure imgf000016_0001
[1]
Figure imgf000016_0001
〔式中、 は水素原子またはメチル基を示し、 R 2は 1〜4個の炭素原子を有す るアルキレン基を示し、 R 3および R 4は同一または異なって 1〜4個の炭素原子 を有するアルキル基を示し、 Aは酸素原子または NHを示す。 〕 [In the formula, represents a hydrogen atom or a methyl group, R 2 represents an alkylene group having 1 to 4 carbon atoms, and R 3 and R 4 represent the same or different and have 1 to 4 carbon atoms. A represents an oxygen atom or NH. ]
で表される重合性ビニル単量体 1 0〜5 0重量%、 重合性ビニル基を有する有機 酸またはその塩 1 0〜5 0重量%および他の重合性ビエル単量体 0〜 8 0重量% を共重合させて得られる樹脂を含む請求項 1に記載の樹脂組成物。 10 to 50% by weight of a polymerizable vinyl monomer represented by the following formula, 10 to 50% by weight of an organic acid having a polymerizable vinyl group or a salt thereof, and 0 to 80% by weight of another polymerizable Bier monomer The resin composition according to claim 1, comprising a resin obtained by copolymerizing% by weight.
3 . (ィ) 脱ァセチル化度が 6 0モル%以上のキトサンを酸で溶解して得られ る溶解液から、 或いは (口) 脱ァセチル化度が 6 0モル%以上のキトサンを酸性 の重合性ビニル単量体の少なくとも 1種で溶解した後、 重合または共重合させて 得られる重合体または共重合体を含有する溶液から、 得られる樹脂を含む請求項 1に記載の樹脂組成物。  3. (a) Acidic polymerization of chitosan with a degree of deacetylation of 60 mol% or more from a solution obtained by dissolving chitosan with an acid or (mouth) chitosan with a degree of deacetylation of 60 mol% or more 2. The resin composition according to claim 1, comprising a resin obtained from a solution containing a polymer or a copolymer obtained by dissolving with at least one kind of a vinyl monomer and then polymerizing or copolymerizing.
4 . ポリビニルアルコールおよび/またはその誘導体の存在下に、 重合性ビニ ル基を有する有機酸またはその塩およびその他の重合性ビニル単量体からなる群 から選択される少なくとも 1種を重合または共重合して得られる樹脂を含む請求 項 1に記載の樹脂組成物。 4. A group consisting of an organic acid having a polymerizable vinyl group or a salt thereof and other polymerizable vinyl monomers in the presence of polyvinyl alcohol and / or a derivative thereof. The resin composition according to claim 1, comprising a resin obtained by polymerizing or copolymerizing at least one selected from the group consisting of:
PCT/JP2001/007343 2000-08-29 2001-08-28 Resin composition WO2002018494A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280194A AU2001280194A1 (en) 2000-08-29 2001-08-28 Resin composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000259827 2000-08-29
JP2000-259827 2000-08-29

Publications (1)

Publication Number Publication Date
WO2002018494A1 true WO2002018494A1 (en) 2002-03-07

Family

ID=18747947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/007343 WO2002018494A1 (en) 2000-08-29 2001-08-28 Resin composition

Country Status (2)

Country Link
AU (1) AU2001280194A1 (en)
WO (1) WO2002018494A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006106799A1 (en) * 2005-03-31 2006-10-12 Shionogi & Co., Ltd. Microcapsule using polyvinyl alcohol copolymer
US8277844B2 (en) 2003-08-20 2012-10-02 Shionogi & Co., Ltd. Coating composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53132091A (en) * 1977-04-21 1978-11-17 Oreal Novel copolymer producing process of said copolymer and cosmetic mixture containing said copolymer
JPH03134038A (en) * 1989-10-19 1991-06-07 Negami Kogyo Kk Particulate material containing chitosan and production thereof
JPH04132705A (en) * 1990-01-05 1992-05-07 Mitsubishi Paper Mills Ltd Production of hydrophilic fine grain
JPH0625433A (en) * 1992-04-30 1994-02-01 Aisero Kagaku Kk Chitosan molding having good water resistance and its production
JPH06116339A (en) * 1990-07-21 1994-04-26 Hoechst Ag Hydrophilic copolymers and their use in reprography
JPH06157677A (en) * 1992-11-25 1994-06-07 Mitsubishi Rayon Co Ltd Production of high-acid-value acrylic resin
JPH06298866A (en) * 1993-04-16 1994-10-25 Nippon Shokubai Co Ltd Biodegradable water-soluble polymer, its production and its use
JPH0873527A (en) * 1994-09-02 1996-03-19 Nitto Chem Ind Co Ltd Production of aqueous solution of amphoteric polymer
JPH10237106A (en) * 1997-02-20 1998-09-08 Omikenshi Co Ltd Production of acylated chitin and chitosan, and molded products thereof
EP0974365A1 (en) * 1998-07-20 2000-01-26 Permatec Technologie Ag Use of an acrylic-type polymer as desintregrating agent

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53132091A (en) * 1977-04-21 1978-11-17 Oreal Novel copolymer producing process of said copolymer and cosmetic mixture containing said copolymer
JPH03134038A (en) * 1989-10-19 1991-06-07 Negami Kogyo Kk Particulate material containing chitosan and production thereof
JPH04132705A (en) * 1990-01-05 1992-05-07 Mitsubishi Paper Mills Ltd Production of hydrophilic fine grain
JPH06116339A (en) * 1990-07-21 1994-04-26 Hoechst Ag Hydrophilic copolymers and their use in reprography
JPH0625433A (en) * 1992-04-30 1994-02-01 Aisero Kagaku Kk Chitosan molding having good water resistance and its production
JPH06157677A (en) * 1992-11-25 1994-06-07 Mitsubishi Rayon Co Ltd Production of high-acid-value acrylic resin
JPH06298866A (en) * 1993-04-16 1994-10-25 Nippon Shokubai Co Ltd Biodegradable water-soluble polymer, its production and its use
JPH0873527A (en) * 1994-09-02 1996-03-19 Nitto Chem Ind Co Ltd Production of aqueous solution of amphoteric polymer
JPH10237106A (en) * 1997-02-20 1998-09-08 Omikenshi Co Ltd Production of acylated chitin and chitosan, and molded products thereof
EP0974365A1 (en) * 1998-07-20 2000-01-26 Permatec Technologie Ag Use of an acrylic-type polymer as desintregrating agent

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277844B2 (en) 2003-08-20 2012-10-02 Shionogi & Co., Ltd. Coating composition
US8552102B2 (en) 2003-08-20 2013-10-08 Shionogi & Co., Ltd. Coating composition
WO2006106799A1 (en) * 2005-03-31 2006-10-12 Shionogi & Co., Ltd. Microcapsule using polyvinyl alcohol copolymer
JPWO2006106799A1 (en) * 2005-03-31 2008-09-11 塩野義製薬株式会社 Microcapsules using polyvinyl alcohol copolymer

Also Published As

Publication number Publication date
AU2001280194A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
CA2419825C (en) Hard capsule made from a polymer or copolymer formed by polymerizing at least one polymerizable vinyl monomer in the presence of polyvinylalcohol or a derivative thereof
JP2535785B2 (en) Vascular embolic agent
US5607417A (en) Compositions and devices for controlled release of active ingredients
CA1225030A (en) Crosslinked, porous polymers for controlled drug delivery
JP2693042B2 (en) Hydrolyzable hydrophilic gel and method for producing the same
US5788687A (en) Compositions and devices for controlled release of active ingredients
CA2044776C (en) Superabsorbent crosslinked ampholytic ion pair copolymers
EP1657265A1 (en) Novel coating composition
JP5730205B2 (en) Coating composition
JP2008522989A5 (en)
JP5394746B2 (en) Particulate crosslinked polyvinylpyrrolidone as a tablet disintegrant
JP2005538193A (en) Controlled release substance
Işıklan et al. Development and characterization of dual sensitive poly (N, N-diethyl acrylamide) grafted alginate microparticles
KR101344857B1 (en) A water soluble film for effective component delivery
WO2002018494A1 (en) Resin composition
Suhail et al. In-vitro and in-vivo evaluation of biocompatible polymeric microgels for pH-driven delivery of Ketorolac tromethamine
Ali et al. Radiation synthesis of poly (ethylene glycol)/acrylic acid hydrogel as carrier for site specific drug delivery
AU2003288706B2 (en) pH sensitive polymer and process for preparation thereof
EP2540286A1 (en) Hard capsule and method for producing same
Deng et al. Drug release behaviors of a pH/temperature sensitive core-shelled bead with alginate and poly (N-acryloyl glycinates)
JPS611624A (en) Method of coating medicine
JP2014118473A (en) Composition for coating
Ranjha pH-sensitive hydrogels for site-specific drug delivery Il. Drug release behaviour from crosslinked alkyl acrylates/methacrylic acid copolymers
Mutar Chloramphenicol controlled release from Poly (acrylic acid-co-methyl methacrylate) hydrogels
JP4808332B2 (en) Method for producing polymer dispersion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP